retatrutide fda approval status 2024 Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation found. Adam When Will Retatrutide Be FDA
Description
Here is what the evidence currently supports, condition by condition, with an honest assessment of where the data stands

In one report, patients who lost more than five pounds after starting semaglutide showed reductions in TSH, suggesting that thyroid labs may shift during the early weight-loss phase

There should ALWAYS be equipment and trained staff for immediate rapid sequence induction during these procedures

Martnez-Puig D et al

Bariatric surgery has important weight loss-dependent and weight loss-independent mechanisms for the induction of resolution of T2DM